본문 바로가기

NSAID-activated gene 1 and its implications for mucosal integrity and intervention beyond NSAIDs

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
PHARMACOLOGICAL RESEARCH121 · pp.122 · 2017
피인용
Web of Science 8Scopus 8
FWCI (Scopus)
0.24
JCR IF
JCR 2016 4.48
ISSN
1043-6618

저자

  1. 문유석제1저자교신저자Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, Pusan National University School of Medicine, Yangsan, South Korea

초록

In spite of the beneficial actions of non-steroid anti-inflammatory drugs (NSAIDs) in epithelial inflammation and cancers, their use is limited because of their cyclooxygenase-dependent or independent gastrointestinal toxicity. As an eicosanoid-independent mediator, NSAID-activated gene 1 (NAG-1) has been assessed for its involvement in cellular integrity and pathogenesis in mucosal inflammation and carcinogenesis. At the cellular levels, NAG-1 is involved in the cell growth regulation (cell death, cell cycle arrest, or proliferation) in epithelial and mesenchymal tissues. Moreover, NAG-1 can modulate inflammatory responses in either direct or indirect manner, which ultimately affects fibrogenic and tumorigenic processes in various disease states. Finally, NAG-1 has been assessed for its contribution to cellular behavior, such as the mobility of epithelial and malignant cells in response to the external insults or oncogenic stimulation in the mucosa. This review on the "Yin-Yang" nature of NAG-1-mediated responses provides comprehensive insights into therapeutic and diagnostic interventions for mucosal health and integrity in the human body. (C) 2017 Elsevier Ltd. All rights reserved.

키워드

NAG-1Mucosal inflammationTumorigenesisFibrogenesisMACROPHAGE-INHIBITORY CYTOKINEGROWTH-DIFFERENTIATION FACTOR-15NONSTEROIDAL ANTIINFLAMMATORY DRUGSPROSTATE-CANCER CELLSTGF-BETA SUPERFAMILYBONE MORPHOGENETIC PROTEINCOLON-CARCINOMA CELLSCYCLOOXYGENASE INHIBITORSESCHERICHIA-COLICOLORECTAL-

식별자

Scopus EID
2-s2.0-85018760374
WoS UID
000404490100012